Skip to content
Menu

Disc Medicine Q3 EPS $(1.53) Beats $(1.76) Estimate

Benzinga Newsdesk 2 weeks ago

NewsEarningsEarnings Beats

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Disc Medicine (NASDAQ:IRON) reported quarterly losses of $(1.53) per share which beat the analyst consensus estimate of $(1.76) by 13.07 percent. This is a 13.56 percent increase over losses of $(1.77) per share from

Disc Medicine (NASDAQ:IRON) reported quarterly losses of $(1.53) per share which beat the analyst consensus estimate of $(1.76) by 13.07 percent. This is a 13.56 percent increase over losses of $(1.77) per share from the same period last year.

Read at benzinga.com